Children with tuberculosis who received 3 months of directly observed preventative therapy were 25 times more likely to complete their treatment regimen than those who received 9 months of self-administered therapy.
The update includes 30 new medicines for adults and 25 for children and groups antibiotics into 3 distinct categories.
The USPSTF task force reviewed evidence regarding screening for LTBI in asymptomatic adults.
The USPSTF concludes with moderate certainty a moderate net benefit in screening at-risk adults for latent tuberculosis infection (LTBI).
Pulmonary tuberculosis smear-positive for acid-fast bacilli was confirmed in all case patients.
New TB assay detects drug-resistant strains in about two hours.
Bedaquiline (Sirturo) has been granted accelerated approval to be used as part of combination therapy to treat adults with MDR-TB.
New recommendations state that all patients with HIV be treated with antiretroviral therapy (ART) regardless of CD4 cell count.
For HIV-infected adults with a positive tuberculin skin test, TB Prophylaxis with isoniazid for 36 months appears more effective than for six months.
Are health care providers performing proper follow-up for patients who where previously diagnosed with BCG vaccine who have positive skin tests for tuberculosis?
Despite advances in disease prevention, nation's 2010 tuberculosis eradication goal not met.
Given the number of immigrants from Third World countries, why are medical providers still teaching that BCG vaccine provides lifelong protection against TB?
When x-rays are not available, should asymptomatic employees be allowed to return to work?
What risks are involved?